Dacarbazine-impurities | Pharmaffiliates

dacarbazine

Dacarbazine was approved for medical use in the United States in 1975. It is also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma.. Reference standards of Dacarbazine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

No Data Found